Coverage of each measure, and prevalence reductions at the end of four years compared with the initial prevalence (0.046% of symptomatic humans and 27% of seropositive dogs, without control measures) and their associated costs.
收藏数据链接：
官方服务：
资源简介：
Coverage of each measure, and prevalence reductions at the end of four years compared with the initial prevalence (0.046% of symptomatic humans and 27% of seropositive dogs, without control measures) and their associated costs.
创建时间：
2020-07-21
